AEZS

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Aeterna Zentaris (AEZS - Research Report), with a price target of $28.00. The company's shares closed last Friday at $4.35.Selvaraju covers the Healthcare sector, focusing on stocks such as Genmab, Aeterna Zentaris, and Regulus. According to TipRanks, Selvaraju has an average return of -31.1% and a 18.39% success rate on recommended stocks. Currently, the analyst consensus on Aeterna Zentaris is a Moderate Buy with an average price target of $28.00.See today’s best-performing stocks on TipRanks >>The company has a one-year high of $24.38 and a one-year low of $4.12.
https://www.tipranks.com/news/blurbs/h-c-wainwright-reaffirms-their-buy-rating-on-aeterna-zentaris-aezs?utm_source=advfn.com&utm_medium=referral